D Wade

Summary

Affiliation: University of Melbourne
Country: Australia

Publications

  1. ncbi request reprint Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis
    Darryl Wade
    Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
    J Clin Psychiatry 68:767-74. 2007
  2. doi request reprint Examination of the latent factor structure of the Alcohol Use Disorders Identification Test in two independent trauma patient groups using confirmatory factor analysis
    Darryl Wade
    Australian Centre for Posttraumatic Mental Health and Department of Psychiatry, University of Melbourne, Victoria, Australia
    J Subst Abuse Treat 43:123-8. 2012
  3. ncbi request reprint Substance misuse in first-episode psychosis: 15-month prospective follow-up study
    D Wade
    ORYGEN Youth Health and Department of Psychiatry, University of Melbourne, Parkville, and Department of Medicine, University of Melbourne at St Vincent s Hospital, Fitzroy, Victoria, Australia
    Br J Psychiatry 189:229-34. 2006
  4. ncbi request reprint Pattern and correlates of inpatient admission during the initial acute phase of first-episode psychosis
    Darryl Wade
    ORYGEN Youth Health and Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
    Aust N Z J Psychiatry 40:429-36. 2006
  5. ncbi request reprint Course of substance misuse and daily tobacco use in first-episode psychosis
    Darryl Wade
    ORYGEN Youth Health, Locked Bag 10, Parkville, VIC 3052, Australia
    Schizophr Res 81:145-50. 2006
  6. doi request reprint Differential predictors of critical comments and emotional over-involvement in first-episode psychosis
    M Alvarez-Jimenez
    Orygen Youth Health Research Centre, Melbourne, Victoria, Australia
    Psychol Med 40:63-72. 2010
  7. ncbi request reprint Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis
    Darryl Wade
    ORYGEN Youth Health and Department of Psychiatry, University of Melbourne, Victoria, Australia
    Aust N Z J Psychiatry 39:892-8. 2005
  8. ncbi request reprint Efficacy of amisulpride in treating primary negative symptoms in first-episode psychosis: a pilot study
    Brendan P Murphy
    ORYGEN Youth Heath, Melbourne, Australia
    Hum Psychopharmacol 21:511-7. 2006
  9. ncbi request reprint Antibodies to infectious agents in individuals at ultra-high risk for psychosis
    G Paul Amminger
    ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Australia
    Biol Psychiatry 61:1215-7. 2007
  10. ncbi request reprint Cannabis use and schizophrenia
    Darryl Wade
    Am J Psychiatry 162:401; author reply 402. 2005

Detail Information

Publications11

  1. ncbi request reprint Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis
    Darryl Wade
    Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
    J Clin Psychiatry 68:767-74. 2007
    ..To investigate whether severity of substance use disorder is independently associated with 15-month symptomatic or functional outcome in young individuals with first-episode psychosis...
  2. doi request reprint Examination of the latent factor structure of the Alcohol Use Disorders Identification Test in two independent trauma patient groups using confirmatory factor analysis
    Darryl Wade
    Australian Centre for Posttraumatic Mental Health and Department of Psychiatry, University of Melbourne, Victoria, Australia
    J Subst Abuse Treat 43:123-8. 2012
    ..An algorithm is proposed to inform alcohol screening protocols in a range of health settings for trauma-exposed patient groups...
  3. ncbi request reprint Substance misuse in first-episode psychosis: 15-month prospective follow-up study
    D Wade
    ORYGEN Youth Health and Department of Psychiatry, University of Melbourne, Parkville, and Department of Medicine, University of Melbourne at St Vincent s Hospital, Fitzroy, Victoria, Australia
    Br J Psychiatry 189:229-34. 2006
    ..Well-designed prospective studies of substance misuse in first-episode psychosis can improve our understanding of the risks associated with comorbid substance misuse and psychosis...
  4. ncbi request reprint Pattern and correlates of inpatient admission during the initial acute phase of first-episode psychosis
    Darryl Wade
    ORYGEN Youth Health and Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
    Aust N Z J Psychiatry 40:429-36. 2006
    ..The second aim was to determine whether the pattern of inpatient admission during this period was associated with remission of psychotic symptoms or inpatient service use at 15-month follow-up...
  5. ncbi request reprint Course of substance misuse and daily tobacco use in first-episode psychosis
    Darryl Wade
    ORYGEN Youth Health, Locked Bag 10, Parkville, VIC 3052, Australia
    Schizophr Res 81:145-50. 2006
    ..Study of the course of substance misuse and daily tobacco use in first-episode psychosis may enhance detection and treatment of these substance-related problems...
  6. doi request reprint Differential predictors of critical comments and emotional over-involvement in first-episode psychosis
    M Alvarez-Jimenez
    Orygen Youth Health Research Centre, Melbourne, Victoria, Australia
    Psychol Med 40:63-72. 2010
    ..Carers were reassessed at 7 months follow-up...
  7. ncbi request reprint Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis
    Darryl Wade
    ORYGEN Youth Health and Department of Psychiatry, University of Melbourne, Victoria, Australia
    Aust N Z J Psychiatry 39:892-8. 2005
    ..To investigate the patterns and predictors of substance use disorders (SUD) and daily tobacco use in first-episode psychosis (FEP)...
  8. ncbi request reprint Efficacy of amisulpride in treating primary negative symptoms in first-episode psychosis: a pilot study
    Brendan P Murphy
    ORYGEN Youth Heath, Melbourne, Australia
    Hum Psychopharmacol 21:511-7. 2006
    ..We undertook a prospective, open-label pilot trial to investigate the use of amisulpride in the treatment of young people with FEP characterised by primary negative symptoms...
  9. ncbi request reprint Antibodies to infectious agents in individuals at ultra-high risk for psychosis
    G Paul Amminger
    ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Australia
    Biol Psychiatry 61:1215-7. 2007
    ..While there is evidence that some cases of schizophrenia may be associated with microbial infections, the role of microbial agents has not been investigated in people with emerging psychosis...
  10. ncbi request reprint Cannabis use and schizophrenia
    Darryl Wade
    Am J Psychiatry 162:401; author reply 402. 2005
  11. ncbi request reprint A service response to prolonged recovery in early psychosis
    Jane Edwards
    Mental Health Services for Kids and Youth, North West Mental Health Program, Parville, Victoria, Australia
    Psychiatr Serv 53:1067-9. 2002